Have you been injured by Skelid? Lawsuits are currently being investigated nationwide alleging that manufacturers of osteoporosis drugs like Skelid put profits over patient safety. Sadly, more and more juries are finding that drug companies valued their shareholders more than the people they were supposed to help.
Skelid Update 6/28/12: In a new web guide published by the FDA, the administration lays out new guidance for the use of bisphosphonates, tentatively recommending a three to five year time limit for the drugs, at least until more conclusive data becomes available. The five-year time limit was originally suggested in a September 2011 report issued by the FDA, which concluded that there appears to be no tangible benefit to extending bisphosphonate regimens beyond five years. Click here to learn more.
Skelid Bone Fracture Update 5/24/12: In a study published this week by the Archives of Internal Medicine, Swiss researchers reached conclusions similar to those reached earlier this month by the U.S. Food & Drug Administration (FDA) – that taking osteoporosis drugs from the bisphosphonate class can increase the risk of atypical bone fractures. Taken cumulatively, the results of the study seem to suggest that the risk of fractures increased over time while the benefits of the drugs decreased. Click here to learn more.
Free Skelid Case Evaluation: If you or a loved one has been injured by Skelid, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.
What’s the problem?
Skelid (tiludronate) is a prescription medication used for the treatment of osteoporosis and Paget’s disease that works by slowing down the breakdown of bone, thus allowing the body to build bone normally. Tiludronate belongs to a class of drugs known as bisphosphonates (bis FOS fo nayts) that are designed to alter the cycle of bone formation in the body. Unfortunately, some patients using Skelid may develop one or more of the following side effects.
Skelid Side Effects
There are a variety of side effects associated with Skelid. Our firm is pursing the following types of severe side effects:
- Osteonecrosis of the Jaw (Dead Jaw)
- Atypical femur fractures
- Swelling or infection of the gums
- Loosening of the teeth
- Poor healing of the gums
- Numbness or a feeling of heaviness in the jaw
- Exposed bone
- Hip Fractures
- Renal failure
On October 13, 2010, the U.S. Food & Drug Administration (FDA) alerted the public about the risks of atypical fractures of the thigh, known as subtrochanteric and diaphyseal femur fractures, in patients who take bisphosphonates for osteoporosis. FDA required that the new information be added to the Warnings and Precautions section of the labels of all bisphosphonate drugs approved for the prevention or treatment of osteoporosis.
“Atypical subtrochanteric femur fractures are fractures in the bone just below the hip joint. Diaphyseal femur fractures occur in the long part of the thigh bone. These fractures are very uncommon and appear to account for less than 1% of all hip and femur fractures overall. Although it is not clear if bisphosphonates are the cause, these unusual femur fractures have been predominantly reported in patients taking bisphosphonates.”
Other osteoporosis medications in the bisphosphonate class include:
Skelid is classified by the FDA in Pregnancy Category C, which means that it is not known whether tiludronate has the potential to cause birth defects. It is not known whether Skelid can pass into breast milk or harm a nursing baby. If you are pregnant or planning to become pregnant, consult your healthcare professional before taking Skelid.
Do I have a Skelid Lawsuit?
The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Skelid lawsuits. We are handling individual litigation nationwide and currently accepting new bone injury cases in all 50 states.